Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Clin Exp Pathol ; 8(5): 4418-26, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26191133

RESUMEN

The diagnosis of uterine smooth muscle tumors including leiomyosarcomas (LMS), smooth muscle tumors of uncertain malignant potential (STUMP), bizarre (atypical) leiomyoma (BLM), mitotically active leiomyoma (MAL) and leiomyoma (LM) depends on a combination of microscopic features, such as mitoses, cytologic atypia, and coagulative tumor cell necrosis. However, a small number of these tumors still pose difficult diagnostic challenges. The assessment of accurate mitotic figures (MF) is one of the major parameters in the proper classification of uterine smooth muscle tumors. This assessment can be hampered by the presence of increased number of apoptotic bodies or pyknotic nuclei, which frequently mimic mitoses. Phospho-histone H3 (PHH3) is a recently described immunomarker specific for cells undergoing mitoses. In our study, we collected 132 cases of uterine smooth muscle tumors, including 26 LMSs, 16 STUMPs, 30 BLMs, 30 MALs and 30 LMs. We used mitosis specific marker PHH3 to count mitotic indexes (MI) of uterine smooth muscle tumors and compared with the mitotic indexes of hematoxylin and eosin (H&E). There is a positive correlation with the number of mitotic figures in H&E-stained sections and PHH3-stained sections (r=0.944, P<0.05). The ratio of PHH3-MI to H&E-MI has no statistically significant difference in each group except for LMs (P>0.05). The counting value of PHH3 in LMSs have significantly higher than STUMPs, BLMs, MALs and LMs (P<0.001) and the counting value of PHH3 is 1.5±0.5 times of the number of mitotic indexes in H&E. To conclude, our results show that counting PHH3 is a useful index in the diagnosis of uterine smooth muscle tumors and it can provide a more accurate index instead of the time-honored mitotic figure counts at a certain ratio.


Asunto(s)
Biomarcadores de Tumor/análisis , Histonas/análisis , Leiomioma/diagnóstico , Leiomiosarcoma/diagnóstico , Neoplasias Uterinas/diagnóstico , Adulto , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Índice Mitótico , Fosforilación , Estudios Retrospectivos
2.
Int J Clin Exp Pathol ; 7(12): 8996-9001, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25674278

RESUMEN

Malignant germ cell tumors of the ovary are very rare and account for about 2-5% of all ovarian tumors of germ origin. Most patients are adolescent and young women, approximately two-thirds of them are under 20 years of age, occasionally in postmenopausal women. But clear cell carcinoma usually occurs in older patients (median age: 57-year old), and closely related with endometriosis. Here we report a case of a 55-year old woman with right ovarian mass that discovered by B ultrasonic. Her serum levels of human chorionic gonadotropin (hCG) and α-fetoprotein (AFP) were elevated. Pathological examination revealed the tumor to be a mixed germ cell tumor (yolk sac tumor, embryonal carcinoma and mature teratoma) with clear cell carcinoma in a background of endometriosis. Immunohistochemical staining showed SALL4 and PLAP were positive in germ cell tumor area, hCG, CD30 and OCT4 were positive in epithelial-like cells and giant synctiotrophoblastic cells, AFP, AAT, CD117 and Glyp3 were positive in yolk sac component, EMA and CK7 were positive in clear cell carcinoma, CD10 was positive in endometrial cells of endometriotic area. She was treated with surgery followed by seven courses of chemotherapy. She is well and serum levels of hCG and AFP have been decreased to normal levels.


Asunto(s)
Carcinoma Embrionario/patología , Tumor del Seno Endodérmico/patología , Neoplasias Complejas y Mixtas/patología , Neoplasias Ováricas/patología , Posmenopausia , Teratoma/patología , Biomarcadores de Tumor/sangre , Biopsia , Carcinoma Embrionario/sangre , Carcinoma Embrionario/química , Carcinoma Embrionario/diagnóstico por imagen , Carcinoma Embrionario/terapia , Gonadotropina Coriónica/sangre , Tumor del Seno Endodérmico/sangre , Tumor del Seno Endodérmico/química , Tumor del Seno Endodérmico/diagnóstico por imagen , Tumor del Seno Endodérmico/terapia , Endometriosis/patología , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Neoplasias Complejas y Mixtas/sangre , Neoplasias Complejas y Mixtas/química , Neoplasias Complejas y Mixtas/diagnóstico por imagen , Neoplasias Complejas y Mixtas/terapia , Neoplasias Ováricas/sangre , Neoplasias Ováricas/química , Neoplasias Ováricas/diagnóstico por imagen , Neoplasias Ováricas/terapia , Teratoma/sangre , Teratoma/química , Teratoma/diagnóstico por imagen , Teratoma/terapia , Resultado del Tratamiento , Ultrasonografía , alfa-Fetoproteínas/metabolismo
3.
Zhonghua Bing Li Xue Za Zhi ; 41(11): 733-6, 2012 Nov.
Artículo en Chino | MEDLINE | ID: mdl-23302332

RESUMEN

OBJECTIVE: To investigate the expression of DNA mismatch repair (MMR) genes (MLH1, MSH2, MSH6 and PMS2) in endometrial adenocarcinoma (EC) of patients under 50 years and to explore the relationship between MMR expression and clinicopathological features including body mass index (BMI), histological grade and pathological stage of EC. METHODS: MMR gene expression was investigated by immunohistochemical S-P method in endometrial adenocarcinomas of patients under age of 50. The control groups included complexity atypical hyperplasia endometrium (CAHE), simple hyperplasia endometrium (SHE), normal endometrium (NE) of patients under age of 50 and EC of patients older than 65 years. RESULTS: Twenty seven of 40 EC (67.5%) lost at least one MMR protein expression. Loss of at least one MMR protein expression was seen in 5/15 cases of CAHE, 1/13 SHE and 1/11 NE, respectively (P < 0.01). The rates of loss of expression of MLH1, MSH2, MSH and PMS2 proteins in EC were 52.5%, 12.5%, 35.0%, and 30.0%, respectively. The difference between MLH1 and MSH6 expression among the four groups were significant (P < 0.05), but the expression of MSH2 showed no significant difference among the groups (P = 0.295). The expression of MMR protein had no relationship with histological grade and pathological stage, although loss of MSH6 was more frequently seen in patients of higher BMI. CONCLUSIONS: Abnormal expression of MMR proteins is correlated with the development of EC from complex atypical hyperplasia. With the exception of the correlation of MSH6 expression with higher BMI, the expression of MMR proteins in EC has no significant relationship with histological grade and pathological stage.


Asunto(s)
Adenocarcinoma/metabolismo , Reparación de la Incompatibilidad de ADN , Enzimas Reparadoras del ADN/metabolismo , Proteínas de Unión al ADN/metabolismo , Neoplasias Endometriales/metabolismo , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Adenocarcinoma/genética , Adenocarcinoma/patología , Adenosina Trifosfatasas/metabolismo , Adulto , Índice de Masa Corporal , Neoplasias Endometriales/genética , Neoplasias Endometriales/patología , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Endonucleasa PMS2 de Reparación del Emparejamiento Incorrecto , Homólogo 1 de la Proteína MutL , Proteína 2 Homóloga a MutS/metabolismo , Clasificación del Tumor , Estadificación de Neoplasias , Proteínas Nucleares/metabolismo
4.
Artículo en Chino | MEDLINE | ID: mdl-12869991

RESUMEN

OBJECTIVE: To understand antibody responses to and RNA sequences of Hantavirus in patients with hemorrhagic fever renal syndrome (HFRS) in Yantai areas and to demonstrate the type of the prevalent viruses caused HFRS. METHODS: Serum specimens collected at acute and convalescent stages from 90 patients with HFRS and IgM and IgG antibodies against Hantavirus were detected with ELISA, and cross plaque reduction neutralizing tests were performed to detect neutralizing antibody. Viral RNA was extracted from the patients? sera by using Trizol method and nested PCR was utilized to amplify the specific segments of the viral cDNA and the products of the PCR were TA cloned and then the nucleotide sequences were determined. RESULTS: The IgM antibody was positive in 82.2% (88/107) of the patients while the IgG antibody was positive in 85.7% (66/77) of the patients. Both the serologic and sequence analyses demonstrated that the epidemic of HFRS in Yantai areas was caused by mixed types of Hantavirus. The prevalent strains of Hantavirus had higher homology with the strains isolated in Korea than with those isolated previously in China. CONCLUSIONS: The serologic and sequencing analyses indicated that the epidemic of HFRS in Yantai areas was caused by mixed types of Hantavirus dominated by type SEO.


Asunto(s)
Anticuerpos Antivirales/sangre , ADN Viral/análisis , Virus Hantaan/genética , Fiebre Hemorrágica con Síndrome Renal/virología , Secuencia de Bases , China , Reservorios de Enfermedades , Virus Hantaan/clasificación , Virus Hantaan/inmunología , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Datos de Secuencia Molecular , Análisis de Secuencia de ADN , Serotipificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA